サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1481811

軟骨変性の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Cartilage Degeneration Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 177 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
軟骨変性の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年05月07日
発行: Value Market Research
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

軟骨変性市場の世界需要は、2023年の120億6,000万米ドルから2032年には約245億3,000万米ドルの市場規模に達すると推定され、調査期間2024～2032年のCAGRは8.21%です。

軟骨変性とは、関節の骨と骨の間のクッションである軟骨組織が徐々に劣化し、痛み、こわばり、関節機能の低下を引き起こすことを指します。軟骨変性は一般的に、加齢、摩耗、反復性ストレス、変形性関節症などの関節損傷と関連しています。関節の可動性の低下、炎症、骨棘の発生を招くこともあります。膝、腰、背骨、手などの関節に影響を及ぼし、重大な痛みや障害を引き起こします。この変性に対する治療法としては、薬剤療法、生活習慣の改善、理学療法があり、重度の場合は人工関節置換術や軟骨修復術などの外科的介入も行われます。

市場力学

人口の高齢化と変形性関節症のような加齢に伴う関節疾患の蔓延が、軟骨変性の予防や進行を遅らせ、関節機能を改善するための革新的な治療法や療法に対する需要を牽引しています。さらに、スポーツ外傷や外傷に関連した関節損傷が、特に若年層や活動的な人々の軟骨変性例の増加に寄与しており、損傷した軟骨組織を修復・再生するための再生医療アプローチや外科的介入に対する需要を促進しています。さらに、MRIやCTスキャンなどの医療用画像診断技術の進歩により、軟骨変性の早期発見・診断が可能になり、関節機能と可動性を維持するためのタイムリーな介入・治療が可能になります。さらに、バイオテクノロジー企業や学術機関による研究開発への投資拡大が、組織工学、幹細胞治療、成長因子を用いた治療など、軟骨修復・再生療法の技術革新を後押ししています。患者中心のケアと価値別の医療モデルへの注目の高まりは、費用対効果が高く低侵襲な治療への需要を促し、外科的介入や薬理療法と並んで、体重管理、理学療法、生活習慣の改善といった保存的管理戦略を促進しています。しかし、再生医療と代替治療オプションの進歩は、今後数年間の市場成長の課題となる可能性があります。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは軟骨変性の世界市場における各セグメントを包括的に評価することもできます。軟骨変性産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

軟骨変性の市場セグメンテーションでは、国別と地域別のセグメントに関する詳細なデータを提供し、各製品やサービスの対象層を特定するための戦略を支援します。

手技タイプ別

  • 関節置換術
  • 軟骨形成術
  • 骨軟骨移植
  • マイクロフラクチャー
  • 半月板移植
  • 細胞ベースの軟骨表面置換術
  • 自家軟骨細胞移植術
  • その他

用途別

  • 膝
  • 股関節
  • その他

治療提供チャネル別

  • 病院
  • 学術研究機関
  • 専門クリニック
  • 外来手術センター
  • その他

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける軟骨変性市場の現在と将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 軟骨変性-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 軟骨変性の世界市場分析：手技タイプ別

  • 手技タイプ別概要
  • 実績データと予測データ
  • 手技タイプ別分析
  • 関節置換術
  • 軟骨形成術
  • 骨軟骨移植
  • マイクロフラクチャー
  • 半月板移植
  • 細胞ベースの軟骨表面置換術
  • 自家軟骨細胞移植術
  • その他

第6章 軟骨変性の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 膝
  • 股関節
  • その他

第7章 軟骨変性の世界市場分析：治療提供チャネル別

  • 治療提供チャネル別概要
  • 実績データと予測データ
  • 治療提供チャネル別分析
  • 病院
  • 学術・研究機関
  • 専門クリニック
  • 外来手術センター
  • その他

第8章 軟骨変性の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 軟骨変性企業の競合情勢

  • 軟骨変性市場競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation
  • Smith & Nephew Plc
  • B. Braun
  • Medtronic Plc
  • Johnson & Johnson（DePuy Synthes）
  • Osiris Therapeutics Inc.
  • Vericel Corporation
  • Anika Therapeutics Inc.
  • Medipost Co. Ltd.
  • Conmed Corporation
  • Arthrex Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Procedure Type (USD MN)
  • Joint Replacements Market Sales By Geography (USD MN)
  • Chondroplasty Market Sales By Geography (USD MN)
  • Osteochondral Transplants Market Sales By Geography (USD MN)
  • Microfracture Market Sales By Geography (USD MN)
  • Meniscus Transplants Market Sales By Geography (USD MN)
  • Cell-based Cartilage Resurfacing Market Sales By Geography (USD MN)
  • Autologous Chondrocyte Implantation Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Knee Market Sales By Geography (USD MN)
  • Hip Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Treatment Delivery Channel (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Cartilage Degeneration Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cartilage Degeneration Report
  • Market Research Process
  • Market Research Methodology
  • Global Cartilage Degeneration Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Procedure Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Treatment Delivery Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Procedure Type (USD MN)
  • Joint Replacements Market Sales By Geography (USD MN)
  • Chondroplasty Market Sales By Geography (USD MN)
  • Osteochondral Transplants Market Sales By Geography (USD MN)
  • Microfracture Market Sales By Geography (USD MN)
  • Meniscus Transplants Market Sales By Geography (USD MN)
  • Cell-based Cartilage Resurfacing Market Sales By Geography (USD MN)
  • Autologous Chondrocyte Implantation Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Knee Market Sales By Geography (USD MN)
  • Hip Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Delivery Channel (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114478

The global demand for Cartilage Degeneration Market is presumed to reach the market size of nearly USD 24.53 Billion by 2032 from USD 12.06 Billion in 2023 with a CAGR of 8.21% under the study period 2024-2032.

Cartilage degeneration refers to the gradual deterioration of cartilage tissue, which cushions between the bones in joints, leading to pain, stiffness, and loss of joint function. It is commonly associated with aging, wear and tear, repetitive stress, or joint injury, such as osteoarthritis. It can result in reduced joint mobility, inflammation, and the development of bone spurs. It may affect joints, including the knees, hips, spine, and hands, causing significant pain and disability. Treatment options for this degeneration include medications, lifestyle modifications, physical therapy, and, in severe instances, surgical interventions such as joint replacement or cartilage repair procedures.

MARKET DYNAMICS

The aging population and the proliferating prevalence of age-related joint diseases such as osteoarthritis drive the demand for innovative treatments and therapies to prevent or slow down cartilage degeneration and improve joint function. Additionally, sports injuries and trauma-related joint damage contribute to the rise in cartilage degeneration cases, particularly among younger and active individuals, driving demand for regenerative medicine approaches and surgical interventions to repair and regenerate damaged cartilage tissue. Moreover, advancements in medical imaging technologies such as MRI and CT scans enable early detection and diagnosis of cartilage degeneration, allowing for timely intervention and treatment to preserve joint function and mobility. Furthermore, the growing investment in research and development by biotechnology companies and academic institutions drives innovation in cartilage repair and regeneration therapies, including tissue engineering, stem cell therapy, and growth factor-based treatments. The escalating focus on patient-centered care & value-based healthcare models drives demand for cost-effective and minimally invasive treatments, promoting conservative management strategies such as weight management, physical therapy, and lifestyle modifications alongside surgical interventions and pharmacological therapies. However, advancements in regenerative medicine and alternative treatment options may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cartilage Degeneration. The growth and trends of Cartilage Degeneration industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cartilage Degeneration market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Procedure Type

  • Joint Replacements
  • Chondroplasty
  • Osteochondral Transplants
  • Microfracture
  • Meniscus Transplants
  • Cell-based Cartilage Resurfacing
  • Autologous Chondrocyte Implantation
  • Others

By Application

  • Knee
  • Hip
  • Others

By Treatment Delivery Channel

  • Hospitals
  • Academic & Research Institutes
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cartilage Degeneration market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cartilage Degeneration market include Zimmer Biomet Holdings Inc., Stryker Corporation, Smith & Nephew Plc, B. Braun, Medtronic Plc, Johnson & Johnson (DePuy Synthes), Osiris Therapeutics Inc., Vericel Corporation, Anika Therapeutics Inc., Medipost Co. Ltd., Conmed Corporation, Arthrex Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CARTILAGE DEGENERATION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Procedure Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Treatment Delivery Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARTILAGE DEGENERATION MARKET ANALYSIS BY PROCEDURE TYPE

  • 5.1. Overview By Procedure Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Procedure Type
  • 5.4. Joint Replacements Historic and Forecast Sales By Regions
  • 5.5. Chondroplasty Historic and Forecast Sales By Regions
  • 5.6. Osteochondral Transplants Historic and Forecast Sales By Regions
  • 5.7. Microfracture Historic and Forecast Sales By Regions
  • 5.8. Meniscus Transplants Historic and Forecast Sales By Regions
  • 5.9. Cell-based Cartilage Resurfacing Historic and Forecast Sales By Regions
  • 5.10. Autologous Chondrocyte Implantation Historic and Forecast Sales By Regions
  • 5.11. Others Historic and Forecast Sales By Regions

6. GLOBAL CARTILAGE DEGENERATION MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Knee Historic and Forecast Sales By Regions
  • 6.5. Hip Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL CARTILAGE DEGENERATION MARKET ANALYSIS BY TREATMENT DELIVERY CHANNEL

  • 7.1. Overview By Treatment Delivery Channel
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Treatment Delivery Channel
  • 7.4. Hospitals Historic and Forecast Sales By Regions
  • 7.5. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 7.6. Specialty Clinics Historic and Forecast Sales By Regions
  • 7.7. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL CARTILAGE DEGENERATION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CARTILAGE DEGENERATION COMPANIES

  • 9.1. Cartilage Degeneration Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CARTILAGE DEGENERATION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Zimmer Biomet Holdings Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Stryker Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Smith & Nephew Plc
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. B. Braun
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Medtronic Plc
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Johnson & Johnson (DePuy Synthes)
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Osiris Therapeutics Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Vericel Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Anika Therapeutics Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Medipost Co. Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Conmed Corporation
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Arthrex Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies